Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Immunex

Executive Summary

Immunex: Special committee of board of directors rejects American Home Products' offer to buy out the remainder of the company at $14.50 per share. Immunex told AHP "the purchase of the shares of Immunex common stock held by minority shareholders at the price you have proposed would appear to create value for the shareholders of AHP at the expense of the minority shareholders of Immunex." The board committee noted its financial advisor, Alex. Brown, concluded that it "could not provide an opinion that the per-share value of the AHP proposal was fair from a financial point of view to the shareholders unaffiliated with AHP." AHP acquired a majority stake in Immunex when it purchased American Cyanamid in late 1994...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS027228

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel